93 related articles for article (PubMed ID: 16407496)
1. Meta- and reanalysis of gene expression profiles of hot and cold thyroid nodules and papillary thyroid carcinoma for gene groups.
Eszlinger M; Wiench M; Jarzab B; Krohn K; Beck M; Läuter J; Gubała E; Fujarewicz K; Swierniak A; Paschke R
J Clin Endocrinol Metab; 2006 May; 91(5):1934-42. PubMed ID: 16407496
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules.
Finley DJ; Arora N; Zhu B; Gallagher L; Fahey TJ
J Clin Endocrinol Metab; 2004 Jul; 89(7):3214-23. PubMed ID: 15240595
[TBL] [Abstract][Full Text] [Related]
3. Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors.
Eszlinger M; Krohn K; Kukulska A; Jarzab B; Paschke R
Endocr Rev; 2007 May; 28(3):322-38. PubMed ID: 17353294
[TBL] [Abstract][Full Text] [Related]
4. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK
Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390
[TBL] [Abstract][Full Text] [Related]
5. Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy.
Fontaine JF; Mirebeau-Prunier D; Franc B; Triau S; Rodien P; Houlgatte R; Malthièry Y; Savagner F
Oncogene; 2008 Apr; 27(15):2228-36. PubMed ID: 17968324
[TBL] [Abstract][Full Text] [Related]
6. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
[TBL] [Abstract][Full Text] [Related]
7. Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling.
Finley DJ; Lubitz CC; Wei C; Zhu B; Fahey TJ
Thyroid; 2005 Jun; 15(6):562-8. PubMed ID: 16029122
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications.
Jarzab B; Wiench M; Fujarewicz K; Simek K; Jarzab M; Oczko-Wojciechowska M; Wloch J; Czarniecka A; Chmielik E; Lange D; Pawlaczek A; Szpak S; Gubala E; Swierniak A
Cancer Res; 2005 Feb; 65(4):1587-97. PubMed ID: 15735049
[TBL] [Abstract][Full Text] [Related]
9. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings.
Sapio MR; Posca D; Raggioli A; Guerra A; Marotta V; Deandrea M; Motta M; Limone PP; Troncone G; Caleo A; Rossi G; Fenzi G; Vitale M
Clin Endocrinol (Oxf); 2007 May; 66(5):678-83. PubMed ID: 17381488
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
Yu S; Liu Y; Wang J; Guo Z; Zhang Q; Yu F; Zhang Y; Huang K; Li Y; Song E; Zheng XL; Xiao H
J Clin Endocrinol Metab; 2012 Jun; 97(6):2084-92. PubMed ID: 22472564
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of gene expression profiles in thyroid nodule biopsy material to diagnose thyroid cancer.
Durand S; Ferraro-Peyret C; Selmi-Ruby S; Paulin C; El Atifi M; Berger F; Berger-Dutrieux N; Decaussin M; Peix JL; Bournaud C; Orgiazzi J; Borson-Chazot F; Rousset B
J Clin Endocrinol Metab; 2008 Apr; 93(4):1195-202. PubMed ID: 18211972
[TBL] [Abstract][Full Text] [Related]
13. A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping.
Fujarewicz K; Jarzab M; Eszlinger M; Krohn K; Paschke R; Oczko-Wojciechowska M; Wiench M; Kukulska A; Jarzab B; Swierniak A
Endocr Relat Cancer; 2007 Sep; 14(3):809-26. PubMed ID: 17914110
[TBL] [Abstract][Full Text] [Related]
14. Spatial spectral imaging as an adjunct to the Bethesda classification of thyroid fine-needle aspiration specimens.
Hahn LD; Hoyt C; Rimm DL; Theoharis C
Cancer Cytopathol; 2013 Mar; 121(3):162-7. PubMed ID: 22833451
[TBL] [Abstract][Full Text] [Related]
15. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
16. Identification of SERPINA1 as single marker for papillary thyroid carcinoma through microarray meta analysis and quantification of its discriminatory power in independent validation.
Vierlinger K; Mansfeld MH; Koperek O; Nöhammer C; Kaserer K; Leisch F
BMC Med Genomics; 2011 Apr; 4():30. PubMed ID: 21470421
[TBL] [Abstract][Full Text] [Related]
17. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma.
Yano Y; Uematsu N; Yashiro T; Hara H; Ueno E; Miwa M; Tsujimoto G; Aiyoshi Y; Uchida K
Clin Cancer Res; 2004 Mar; 10(6):2035-43. PubMed ID: 15041723
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
20. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.
Murphy KM; Chen F; Clark DP
Hum Pathol; 2008 Mar; 39(3):420-6. PubMed ID: 18261626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
